載入...
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
BACKGROUND: The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effe...
Na minha lista:
| 發表在: | Lancet |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8064669/ https://ncbi.nlm.nih.gov/pubmed/33901420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(21)00677-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|